Table 3 Percentage of individuals with type 2 diabetes receiving glucose lowering-, antihypertensive- and lipid lowering medications by ethnicity

N

8495

184

218

798

340

126

 Life style modification alone

34.0 (29.0 to 39.0)

25.7 (17.4 to 33.9)

25.2 (17.7 to 32.7)

29.5 (23.4 to 35.7)

27.9 (20.8 to 35.0)

27.5 (17.2 to 37.7)

 All agents without insulin

51.5 (49.0 to 54.0)

57.5 (49.8 to 65.2)

62.1 (54.2 to 70.0)*

58.6 (53.8 to 63.4)

63.3 (55.2 to 71.4)*

66.7 (56.6 to 76.7)*

 Insulin alone

5.8 (5.2 to 6.4)

6.7 (2.9 to 10.4)

4.3 (1.4 to 7.3)

4.3 (2.8 to 5.8)

2.4 (0.9 to 3.9)*

6.0 (0.8 to 11.1)

 Insulin combined with other agents

9.5 (8.6 to 10.3)

11.7 (7.1 to 16.3)

9.9 (5.5 to 14.4)

16.8 (13.8 to 19.7)*

10.4 (7.1 to 13.6)

7.1 (1.9 to 12.4)

 1

35.6 (33.5 to 37.7)

29.2 (20.8 to 37.6)

42.2 (34.0 to 50.4)

36.6 (33.1 to 40.2)

35.1 (27.2 to 43.0)

47.6 (36.1 to 59.2)

 2

21.7 (20.4 to 23.0)

26.7 (18.9 to 34.5)

23.6 (18.9 to 28.3)

27.7 (22.9 to 32.5)

23.5 (18.9 to 28.1)

27.4 (17.9 to 36.9)

 ≥3

9.5 (8.7 to 10.2)

20.1 (12.5 to 27.5)*

10.6 (5.4 to 15.7)

15.2 (12.8 to 17.7)*

17.5 (12.4 to 22.6)*

4.8 (1.2 to 8.3)

Antihypertensive

66.2 (61.5 to 70.8)

60.1 (51.1 to 69.1)

61.7 (53.4 to 69.9)

53.6 (47.1 to 60.1)*

47.4 (39.6 to 55.3)*

36.1 (25.0 to 47.2)*

Lipid lowering

54.1 (49.8 to 58.4)

53.5 (44.3 to 62.7)

47.8 (39.4 to 56.3)

50.6 (44.6 to 56.6)

46.1 (38.7 to 53.5)

24.0 (14.6 to 33.5)*